Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Gate Bioscience

Gate Bioscience

Series BUSgatebio.com
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$65.0Msum of rounds with a disclosed amount only
Named investors
2
Financing history
1 rounds
  1. Nov 13, 2025
    Series B · $65.0M (disclosed)
    Forbion (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic”
Investors on record
2 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Nov 13, 2025
    Gate Bioscience announced Series B of $65,000,000
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
3 observations
Every observation on this company